Biological processing called biopharmaceutical manufacturing has various systems for upstream processing. Biological process manufacturing is divided into two main processes: upstream and downstream.Upstream processes involve steps such as culture medium development, cell culture, and cell development, harvesting, and fermentation.Examples include bioreactors, membrane absorbers, bioreactors, disposable mixers, and samplers.Upstream bioprocessing equipment for mammalian and bacterial cells involves the production of therapeutic proteins, antibiotics, hormones, enzymes, blood substitutes and vaccines.
This report contains market size and forecasts of Upstream Bioprocessing Equipment in global, including the following market information:
Global Upstream Bioprocessing Equipment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Upstream Bioprocessing Equipment Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Upstream Bioprocessing Equipment companies in 2021 (%)
The global Upstream Bioprocessing Equipment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Continuous Bioprocessing System Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Upstream Bioprocessing Equipment include GE Healthcare, Merck, Thermo Fisher Scientific, Boehringer Ingelheim Pharma GmbH & Co.KG,, BiOZEEN, Katalyst Bio Engineering, ABEC Biopharmaceutical Manufacturing, Bionet Engineering and Lonza- Pharma & Biotech and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Upstream Bioprocessing Equipment manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Upstream Bioprocessing Equipment Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Upstream Bioprocessing Equipment Market Segment Percentages, by Type, 2021 (%)
Continuous Bioprocessing System
Single-Use Bioprocessing System
Global Upstream Bioprocessing Equipment Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Upstream Bioprocessing Equipment Market Segment Percentages, by Application, 2021 (%)
Pharmaceutical & Biological Manufacturing Companies
Research Centers
Global Upstream Bioprocessing Equipment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Upstream Bioprocessing Equipment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Upstream Bioprocessing Equipment revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Upstream Bioprocessing Equipment revenues share in global market, 2021 (%)
Key companies Upstream Bioprocessing Equipment sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Upstream Bioprocessing Equipment sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
GE Healthcare
Merck
Thermo Fisher Scientific
Boehringer Ingelheim Pharma GmbH & Co.KG,
BiOZEEN
Katalyst Bio Engineering
ABEC Biopharmaceutical Manufacturing
Bionet Engineering
Lonza- Pharma & Biotech
Corning